Answers are grounded in this paper and cite their sources.
Background/Objectives: Neuroendocrine carcinoma of the cervix (NECC) is a rare, aggressive variant of cervical cancer (approximately 1–1.5% of cases), and large-cell neuroendocrine carcinoma (LCNEC) is an even rarer subtype. Diagnosis is often delayed because symptoms are non-specific and cytology may fail to detect the disease. We report this case to highlight the diagnostic challenge posed by LCNEC in a young patient with repeatedly normal cytology. Methods: We describe the diagnostic work-up and multimodal management of a 22-year-old woman who presented with post-coital bleeding nine months after her second full-term vaginal delivery. Results: Two Babeș–Papanicolaou smears obtained three months apart were negative for intraepithelial lesion or malignancy. Persistent bleeding prompted a loop electrosurgical excision procedure (LEEP), which revealed a poorly differentiated (high-grade) LCNEC. Clinical examination and MRI showed proximal parametrial involvement and a left external iliac lymph node metastasis (FIGO 2018 stage IIIC1r, cT2bN1M0). The patient received definitive chemoradiotherapy (external beam radiotherapy with a simultaneous integrated boost and high-dose-rate brachytherapy) with six cycles of platinum–etoposide chemotherapy (two concurrent, four adjuvant), achieving a complete response with no evidence of disease approximately three years after treatment. Conclusions: This report illustrates that cytology can be repeatedly negative in NECC and that persistent symptoms or a visible cervical lesion warrant histological evaluation. Given its aggressive clinical course, LCNEC requires the rapid initiation of combined local and systemic therapy.
No takes yet. Share an insight, caveat, or question.
Groza et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: